OR WAIT null SECS
March 08, 2022
CDMO’s Chenôve facility receives investment from French government
March 07, 2022
Deal expected to help expand its API production services
Agreement establishes company’s first mRNA manufacturing facility in Africa
March 02, 2022
The deal features a long-term supply and production agreement between the parties
Expansion features 11 new cGMP labs at Durham, NC location
February 24, 2022
A chat with Cardinal Health’s Joel Wayment, who dives into what can be done to help ensure that patients receive their necessary medications, no matter the conditions
The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
February 22, 2022
Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa
February 18, 2022
CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector
February 17, 2022
Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden